{{Rsnum
|rsid=365066
|Gene=HLA-DOA
|Chromosome=6
|position=33007480
|Orientation=plus
|GMAF=0.4013
|Gene_s=HLA-DOA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.1 | 37.2 | 24.8
| HCB | 21.9 | 49.6 | 28.5
| JPT | 43.4 | 47.8 | 8.8
| YRI | 50.3 | 40.8 | 8.8
| ASW | 49.1 | 36.8 | 14.0
| CHB | 21.9 | 49.6 | 28.5
| CHD | 12.8 | 48.6 | 38.5
| GIH | 43.6 | 36.6 | 19.8
| LWK | 45.5 | 48.2 | 6.4
| MEX | 48.3 | 39.7 | 12.1
| MKK | 37.2 | 51.9 | 10.9
| TSI | 37.3 | 46.1 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23582631
|Title=Pathway analysis of genome-wide association studies on rheumatoid arthritis
}}

{{PMID Auto
|PMID=12830434
|Title=BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}